| Intervention | Epigallocatechin gallate (EGCG) |
| Suggested dose | 4 cups daily or 225 mg po qd |
| Mechanism(s) of action against non-COVID-19 viruses | Favorably modulate viral-induced pathological cellular processes: |
| Outcomes data supporting their mitigating effects on illness from other viral strains | No data available |
| Strength of evidence | Conditional |
| Risk of harm30-35 | Significant (rare)—Hepatotoxicity |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.